IRF2BP2 and hepatocellular carcinoma: Given that IRF2BP2 exhibits potent tumor-suppressor activity in the hepatocellular carcinoma (HCC) [21], we explored whether IRF2BP2 is an authentic SPOP substrate primarily in liver cancer cells.